These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria. Hoppe B; Groothoff JW; Hulton SA; Cochat P; Niaudet P; Kemper MJ; Deschênes G; Unwin R; Milliner D Nephrol Dial Transplant; 2011 Nov; 26(11):3609-15. PubMed ID: 21460356 [TBL] [Abstract][Full Text] [Related]
6. Donor structural and functional parameters are independent predictors of renal function at 3 months. Ibernon M; González-Segura C; Moreso F; Gomà M; Serón D; Fulladosa X; Torras J; Garcia-Huete L; Gil-Vernet S; Cruzado JM; Carrera M; Duarte V; Grinyó JM Transplant Proc; 2007 Sep; 39(7):2095-8. PubMed ID: 17889104 [TBL] [Abstract][Full Text] [Related]
7. Estimated one-yr glomerular filtration rate is an excellent predictor of long-term graft survival in pediatric first kidney transplants. Muscheites J; Wigger M; Drueckler E; Klaassen I; John U; Wygoda S; Fischer DC; Kundt G; Misselwitz J; Müller-Wiefel DE; Haffner D Pediatr Transplant; 2009 May; 13(3):365-70. PubMed ID: 18537896 [TBL] [Abstract][Full Text] [Related]
8. Potential for bilateral nephrectomy to reduce oxalate release after combined liver and kidney transplantation for primary hyperoxaluria type 1. Mizusawa Y; Parnham AP; Falk MC; Burke JR; Nicol D; Yamanaka J; Lynch SV; Strong RW Clin Transplant; 1997 Oct; 11(5 Pt 1):361-5. PubMed ID: 9361924 [TBL] [Abstract][Full Text] [Related]
9. Transplantation procedures in primary hyperoxaluria type 1. Latta A; Müller-Wiefel DE; Sturm E; Kemper M; Burdelski M; Broelsch CE Clin Nephrol; 1996 Jul; 46(1):21-3. PubMed ID: 8832145 [TBL] [Abstract][Full Text] [Related]
10. Erythrocytosis after renal transplantation: risk factors and relationship with GFR. Nankivell BJ; Allen RD; O'Connell PJ; Chapman JR Clin Transplant; 1995 Oct; 9(5):375-82. PubMed ID: 8541630 [TBL] [Abstract][Full Text] [Related]
11. Preemptive kidney transplant from deceased donors: an advantage in relation to reduced waiting list. Pérez-Flores I; Sánchez-Fructuoso A; Calvo N; Marques M; Anaya S; Ridao N; Rodríguez A; Barrientos A Transplant Proc; 2007 Sep; 39(7):2123-4. PubMed ID: 17889112 [TBL] [Abstract][Full Text] [Related]
12. The correlation of renal allograft weight to metabolic index ratios and glomerular filtration rate among living-unrelated kidney transplant patients: a cross-sectional study. Amante AJ; Piñon-Barretto SC Transplant Proc; 2008 Sep; 40(7):2313-8. PubMed ID: 18790222 [TBL] [Abstract][Full Text] [Related]
13. The natural history of renal function following orthotopic heart transplant. Al Aly Z; Abbas S; Moore E; Diallo O; Hauptman PJ; Bastani B Clin Transplant; 2005 Oct; 19(5):683-9. PubMed ID: 16146562 [TBL] [Abstract][Full Text] [Related]
14. One hundred percent patient and kidney allograft survival with simultaneous liver and kidney transplantation in infants with primary hyperoxaluria: a single-center experience. Millan MT; Berquist WE; So SK; Sarwal MM; Wayman KI; Cox KL; Filler G; Salvatierra O; Esquivel CO Transplantation; 2003 Nov; 76(10):1458-63. PubMed ID: 14657686 [TBL] [Abstract][Full Text] [Related]
16. Preemptive living donor renal transplantation: a single-center experience. Haberal M; Karakayali H; Sevmis S; Akbulut S; Colak T; Baskin E; Moray G; Torgay A; Arslan G Transplant Proc; 2009 Sep; 41(7):2764-7. PubMed ID: 19765429 [TBL] [Abstract][Full Text] [Related]
17. Thresholds of serum calcium oxalate supersaturation in relation to renal function in patients with or without primary hyperoxaluria. Marangella M; Cosseddu D; Petrarulo M; Vitale C; Linari F Nephrol Dial Transplant; 1993; 8(12):1333-7. PubMed ID: 8159301 [TBL] [Abstract][Full Text] [Related]
18. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study. Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932 [TBL] [Abstract][Full Text] [Related]
19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]